Literature DB >> 34882894

SARS-CoV-2 vaccine-related adverse events in Zimbabwe: The need to strengthen pharmacovigilance in resource-limited settings.

Grant Murewanhema1, Tafadzwa Dzinamarira2,3, Roda Madziva4, Helena Herrera5, Godfrey Musuka2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34882894     DOI： 10.1002/pds.5393

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  3 in total

1.  Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series.

Authors:  Eric Yuk Fai Wan; Yuan Wang; Celine Sze Ling Chui; Anna Hoi Ying Mok; Wanchun Xu; Vincent Ka Chun Yan; Francisco Tsz Tsun Lai; Xue Li; Carlos King Ho Wong; Esther Wai Yin Chan; Kui Kai Lau; Benjamin John Cowling; Ivan Fan Ngai Hung; Ian Chi Kei Wong
Journal:  Lancet Healthy Longev       Date:  2022-07-04

2.  The COVID-19 Pandemic: Public Health Responses in Sub-Saharan Africa.

Authors:  Grant Murewanhema; Tafadzwa Dzinamarira
Journal:  Int J Environ Res Public Health       Date:  2022-04-07       Impact factor: 3.390

3.  Maternal, Sexual and Reproductive Health in Marginalised Areas: Renewing Community Involvement Strategies beyond the Worst of the COVID-19 Pandemic.

Authors:  Grant Murewanhema; Godfrey Musuka; Chipo Gwanzura; Richard Makurumidze; Itai Chitungo; Munashe Chimene; Nigel Tungwarara; Tafadzwa Dzinamarira; Mugove Gerald Madziyire
Journal:  Int J Environ Res Public Health       Date:  2022-03-14       Impact factor: 3.390
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.